With rising consumer awareness about efficient medical procedures, the demand for minimally invasive procedures is on the rise. Cost-effective and medically sound, these therapies have proven to be beneficially from all angles. The growing implementation of minimally invasive procedures and the presence of advanced healthcare infrastructure in developed countries are promoting the growth of the global inflation device market. Due to an unhealthy lifestyle, there is a growing incidence of CVD, and the less-stringent approval procedures are contributing to the growth of the market. The market is highly unexplored and the dire need for more efficient procedures and reforms are major factors stimulating the growth of the market. With the increase in the geriatric population, the prevalence of coronary artery disease is also expected to increase, which is a major target indication for interventional cardiology procedures that utilizes inflation device to inflate and deflate the balloon.
The spiraling incidence of target diseases, favorable medical reimbursement for minimally invasive procedures in developed countries, and increasing applications of inflation devices are the fundamental determinants driving the growth of the inflation devices market.
Initiatives undertaken by government and non-government organizations to control and manage the weight of healthcare-associated infections (HAI) in developed countries and effectively manage the increasing healthcare expenditure across emerging markets are further assisting market growth.
The increasing adoption of balloon-assisted surgeries that employ inflation devices to swell and deflate the balloon in procedures such as angioplasty, angiography, balloon sinuplasty, catheter embolization is the principal determinant increasing the demand for inflation devices. Moreover, the increase in disposable income and escalating healthcare expenditure, high patient awareness, and favorable reimbursement landscape in most developed countries is also contributing to the market growth.
The market is fairly untapped and the firms are trying to maximise their gains by establishing a strong foothold and presence globally. In 2016, Vascular Solutions, Inc. announced that they have received clearance from the FDA for their fluent inflation device which is specially designed so that they can be used during cardiovascular procedures. The device has the ability to maintain and create pressure in balloon catheters. This launch will help them strengthen their position in the market and will also help the physicians to perform different interventional procedures.
The digital display inflation devices segment is expected to grow at a faster CAGR during the forecast period. The high growth of this segment can be attributed to the advanced display patterns and ease of use associated with these devices. Moreover, an increasing number of local manufacturers manufacturing digital inflation devices at a lower cost as compared to established market players is another important factor contributing to the segment growth.
The interventional cardiology application segment is estimated to command the largest share of the inflation devices market. The majority share of this segment is attributed to the growing prevalence of cardiovascular diseases, rising geriatric population, and the rising preference for minimally invasive surgeries.
The hospitals and clinics segment accounted for the largest market share largely due to the growing number of hospitals and specialty clinics in emerging countries, increasing prevalence of target diseases and a large number of surgical and diagnostic procedures performed across these facilities.
The presence of established firms and developed healthcare facilities in North America makes it a major market. The rising population and increased demand for medical care boosts the market. The APAC region is forecasted to grow at the highest CAGR during the forecast period due to continuous developments.
Recent Developments
In 2016, NuCryo Vascular LLC announced that they have received clearance for their next-generation reusable cryoplasty inflation device PolarCath Peripheral Dilatation System. They are specially designed for the treatment of obstructive lesions of polytetrafluoroethylene and vasculature. This new system can also be used to perform balloon cryoplasty. This will be very useful to treat peripheral arterial disease.
In 2018, ASAHI INTECC CO., LTD. (Japan) entered a partnership agreement with Medtronic plc to exclusively distribute Asahi Intecc’s Neurovascular Guidewire and catheter in the US market.This helped them widen their consumer base. Merit Medical Systems, Inc. (US) acquired products from Argon Medical Devices (US) and Catheter Connections, Inc. (US) and increased its product portfolio. Merit Medical Systems, Inc. (US) also received the US FDA’s 510(k) clearance for the SwiftNINJA Steerable Microcatheter and had also acquired Covidien plc (US). All of these measures helped the firm to promote its services on a global level and maximise trade.
Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=2334&page=requestsample
Global Inflation Device Market Segmentation
By Capacity
● 20ml Inflation Devices
● 30ml Inflation Devices
● 60ml Inflation Devices
By Display Type
● Analog Inflation Devices
● Digital Inflation Devices
By Application
● Interventional Cardiology
● Interventional Radiology
● Peripheral Vascular Procedures
● Gastroenterological Procedures
● Urological Procedures
● Other Applications
By End User
● Hospitals and Clinics
● Ambulatory Surgery Centers
By Region
● Europe
● North America
● APAC
● Latin America
● Rest of World
Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=2334&page=askfordiscount

Competitive Landscape:
● Tier 1 players- established companies in the market with a major market share
● Tier 2 players
● Emerging players which are growing rapidly
● New Entrants
Major firms in the market are Merit Medical Systems (US), Boston Scientific Corporation (US), Cardinal Health (US), CONMED Corporation (US), Medtronic plc (Ireland), Acclarent Inc. (US), Cook Medical (US), Atrion Corporation (US), Becton, Dickinson and Company (US), Terumo Medical Corporation (Japan), B. Braun Melsungen AG (US), Olympus Corporation (Japan), Teleflex Incorporated (US), and US Endovascular (US), among others.
FutureWise Takeaways
● Growth prospects
● SWOT analysis
● Key trends
● Key data points affecting market growth
Objectives of the Study:
● To provide an exhaustive analysis on the global inflation device market by capacity, by display type, by application, by end-user, and by region
● To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
● To evaluate and forecast micro-markets and the overall market
● To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the rest of the world
● To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
● Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Market Estimation Methodology
2.2.1 Product-Based Market Estimation
2.2.2 Primary Research Validation
2.3 Market Breakdown and Data Triangulation
2.4 Research Limitations and Assumptions
2.4.1 Limitations
2.4.2 Assumptions

3 Executive Summary

4 Premium Insights
4.1 Market Overview
4.2 Geographic Analysis: Inflation Device Market, By Display Type and Region
4.3 Geographic Analysis: Market, By Capacity and Region
4.4 Market, By Application
4.5 Geographic Snapshot of the Inflation Device Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Geriatric Population
5.2.1.2 Increasing Preference for Minimally Invasive Surgeries
5.2.1.3 Favorable Reimbursement Scenario for Cardiovascular Procedures
5.2.2 Restraints
5.2.2.1 Availability of Effective Alternative Treatments
5.2.2.2 High Rate of Reprocessing Inflation Devices
5.2.3 Opportunities
5.2.3.1 Emerging Economies Offer High-Growth Potential
5.2.3.2 Rising Awareness About Hospital-Acquired Infections and the Rising Adoption of Disposable Accessories
5.2.4 Challenges
5.2.4.1 Product Recalls
5.2.4.2 Presence of Local Manufacturers and Pricing Pressure

6 Inflation Device Market, By Capacity
6.1 Introduction
6.2 20ml Inflation Devices
6.2.1 Easy Availability of 20ml Inflation Devices and Wide Range of Offerings are Driving the Growth of This Market Segment
6.3 30ml Inflation Devices
6.3.1 30ml Inflation Devices Offer Digital Or Analog Displays
6.4 60ml Inflation Devices
6.4.1 60ml Inflation Devices to Witness Highest Growth During the Forecast Period

7 Inflation Device Market, By Display Type
7.1 Introduction
7.2 Analog Inflation Devices
7.2.1 Analog Inflation Devices Accounted for the Larger Market Share Primarily Due to the Low Cost and Portability Associated With These Devices
7.3 Digital Inflation Devices
7.3.1 High Growth of the Digital Inflation Devices Segment is Attributed to the Advanced Display Patterns and Ease of Use Associated With These Devices

8 Inflation Device Market, By Application
8.1 Introduction
8.2 Interventional Cardiology
8.2.1 Interventional Cardiology Forms the Largest Application Segment of the Inflation Devices Market
8.3 Interventional Radiology
8.3.1 Increasing Prevalence of Cancer to Drive the Adoption of Inflation Devices for This Application Segment
8.4 Peripheral Vascular Procedures
8.4.1 Increasing Prevalence of Target Diseases to Drive the Market for This Application Segment
8.5 Gastroenterological Procedures
8.5.1 Gastroenterological Procedures Segment to Witness the Highest Growth Primarily Due to the Increasing Incidence of Gastrointestinal Diseases Across the Globe
8.6 Urological Procedures
8.6.1 Growing Prevalence of Urological Disorders & Ongoing Technical Advancements in the Field of Minimally Invasive Urological Treatments to Drive Market Growth
8.7 Other Applications

9 Inflation Device Market, By End User
9.1 Introduction
9.2 Hospitals and Clinics
9.2.1 Hospitals Hold the Largest Share of the Market, By End User
9.3 Ambulatory Surgery Centers
9.3.1 Advantages of Ambulatory Care Have Boosted Patient Preference for These Centers

10 Inflation Device Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 US Accounts for the Largest Share of the North American Market
10.2.2 Canada
10.2.2.1 Nearly One-Fifth of the Population Suffers From High Blood Pressure
10.3 Europe
10.3.1 Germany
10.3.1.1 Germany Had Among the Highest Obesity Rates in 2017
10.3.2 UK
10.3.2.1 Rising Geriatric Population and Well-Developed Healthcare Infrastructure Account for Market Growth
10.3.3 France
10.3.3.1 Favorable Government Support has Expanded Healthcare Access and Medical Tourism in France
10.3.4 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.1.1 China’s Aging Population is Growing at A High Rate
10.4.2 Japan
10.4.2.1 Universal Healthcare Coverage has Allowed for Easy Access to Healthcare in Japan
10.4.3 India
10.4.3.1 High Target Patient Population in India Will Drive Market Growth
10.4.4 Rest of Asia Pacific
10.5 Rest of the World

11 Competitive Landscape
11.1 Introduction
11.2 Market Ranking
11.3 Competitive Scenario
11.3.1 Product Launches and Approvals
11.3.2 Acquisitions
11.3.3 Expansions
11.3.4 Partnerships, Agreements, and Collaborations
11.4 Competitive Leadership Mapping: Major Market Players (2018)
11.4.1 Visionary Leaders
11.4.2 Innovators
11.4.3 Dynamic Differentiators
11.4.4 Emerging Companies

12 Company Profiles
(Business Overview, Products Offered, Recent Developments, FutureWise View)*
12.1 Advanced Lifesciences Pvt. Ltd.
12.2 Acclarent, Inc. (Subsidiary of Johnson & Johnson)
12.3 Atrion Corporation
12.4 B. Braun Melsungen AG
12.5 Becton, Dickinson and Company
12.6 Boston Scientific Corporation
12.7 Cardinal Health
12.8 Conmed Corporation
12.9 Cook Medical
12.10 Medtronic PLC
12.11 Merit Medical Systems
12.12 Olympus Corporation
12.13 Teleflex Incorporated
12.14 Terumo Medical Corporation
12.15 US Endovascular
*Business Overview, Products Offered, Recent Developments, FutureWise View Might Not Be Captured in Case of Unlisted Companies.
Inquire further details about this report at: [email protected]

About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com